LobbyingSecretome Therapeutics lobbying by quarter
Secretome Therapeutics's latest lobbying report covers Q2 2026, at $30K. The four quarters Q3 2025–Q2 2026 total $100K. Its first report covers Q3 2025; the issues it reports most are Health Issues.
Secretome Therapeutics
- Latest quarter
- $30K
- Q2 2026 · 1 reports
- Last 12 months
- $100K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $10K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
Policy issues the reports name
- Health issues4 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Thorn Run Partners | $100K | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | Thorn Run Partners | $30K |
| 04/18for Q1 | Thorn Run Partners | $30K |
| 01/20for Q4 2025 | Thorn Run Partners | $30K |
| 25/10/20for Q3 2025 | Thorn Run Partners | $10K |
| 25/09/18for Q3 2025 | Thorn Run Partners | Under $5,000 |